2015 Comment Letters

ADLM continually tracks legislative and regulatory issues of importance to clinical laboratories and the clinical laboratory profession. This is a listing of ADLM's 2015 comment letters. ADLM commented on a wide range of topics to federal and state authorities.

2015 Legislative and Regulatory Issues

AACC Proposes Broadening PAMA Reporting Requirements

NOV.24.2015

AACC Raises Concerns About Expanded FDA Oversight of LDTs

NOV.17.2015

AACC joined with the Friends of AHRQ in opposing cuts in AHRQ spending

OCT.22.2015

AACC endorsed legislation to assist young researchers obtain NIH grants

SEP.03.2015

AACC joined with other groups in supporting funding for an alternative National Children’s Study

AUG.25.2015

AACC provided input to NIH on its new Environmental Influences on Child Health Outcomes Program

AUG.14.2015

AACC joined the Friends of AHRQ in opposing cuts in agency funding

JUL.13.2015

AACC wrote to House leaders opposing efforts to eliminate the Agency for Healthcare Research and Quality

JUL.01.2015

AACC endorsed H.R.1190, the Protecting Seniors' Access to Medicare Act of 2015

JUN.02.2015

AACC endorsed the Next Generation Researchers Act

MAY.29.2015

AACC recommended CMS Establish a Transition Period for Expanded Blood Glucose Monitor Oversight

MAY.04.2015  

AACC joins the Friends of AHRQ in supporting federal funding for AHRQ

MAR.23.2015

AACC wrote to key House and Senate leaders endorsing the President's Personalized Medicine Initiative

MAR.16.2015

AACC urged FDA to maintain current oversight structure for next generation sequencing testing

AACC urged the FDA to maintain the existing regulatory structure for LDTs

JAN.29.2015

AACC provided input regarding the FDA’s notification and medical device reporting proposals for LDTs

JAN.29.2015

AACC and others urged NIH to spend National Children’s Study funds on pediatric research

JAN.21.2015

AACC endorsed H.R.160, the Protect Medical Innovation Act

JAN.14.2015

AACC endorsed S.141, the Protecting Seniors’ Access to Medicare Act

JAN.14.2015

AACC provided testimony at the FDA Workshop on the regulation of LDTs

JAN.08.2015

AACC provided input to the House Energy and Commerce Committee regarding LDTS

JAN.05.2015